|
KMID : 1200020190430040398
|
|
Diabetes & Metabolism Journal
2019 Volume.43 No. 4 p.398 ~ p.406
|
|
|
2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
|
|
Kim Mee-Kyoung
Ko Seung-Hyun
Kim Bo-Yeon
Kang Eun-Seok
Noh Jung-Hyun
Kim Soo-Kyung
Park Seok-O
Hur Kyu-Yeon
Chon Suk
Moon Min-Kyong
Kim Nan-Hee
Kim Sang-Yong
Rhee Sang-Youl
Lee Kang-Woo
Kim Jae-Hyeon
Rhee Eun-Jung
Chun Sung-Wan
Yu Sung-Hoon
Kim Dae-Jung
Kwon Hyuk-Sang
Park Kyong-Soo
|
|
|
Abstract
|
|
|
|
The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations.
|
|
|
KEYWORD
|
|
|
Diabetes mellitus, type 2, Diagnosis, Practice guideline, Therapeutics
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|